Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KTI12 chromatin associated homolog (KTI12) encodes a conserved ATP-binding protein that physically and functionally associates with the Elongator complex, a six-subunit histone acetyltransferase which modifies chromatin and regulates transcription elongation. KTI12 stimulates Elongator’s activity in tRNA wobble uridine modification and is essential for correct tRNA decoding, protein translation, and cell growth in yeast. The protein contains conserved motifs such as a P-loop (NTP binding) and calmodulin-binding domains, has weak direct association with disease, and is not a drug target. Loss-of-function or mutant alleles cause tRNA modification defects and Elongator-related phenotypes, but KTI12 has not been described as a direct pharmacological target or biomarker in humans. KTI12’s main biological role is supporting tRNA modification via the Elongator complex, impacting translation efficiency and accuracy. Variants or mutations in human KTI12 are linked to rare inherited disorders but have not been therapeutically targeted. The yeast KTI12 protein has served as a genetic and mechanistic tool for studying chromatin regulatory pathways and protein translation but is not implicated in canonical signaling, receptor biology, or small molecule drug action. If structured information for clinical pharmacology or biomarker purposes is needed, KTI12 would be classified under chromatin-associated regulatory factors rather than as a receptor, enzyme, transporter, or common drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KTI12 chromatin associated homolog (KTI12).